Journal - Current Drug Discovery Technologies

Topic(s) Covered

3 Topic(s)

View

Aims & Scope

Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing original research papers, full-length/mini reviews, drug clinical trial studies and guest edited thematic issues describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.

Current Drug Discovery Technologies is an essential journal for all scientists and research managers involved in drug discovery who wish to keep abreast of all the modern techniques and technologies used in drug discovery.

Abstracted & Indexed in:

Biological Abstracts BIOSIS Previews British Library Cabell's Directory/Journalytics Cambridge Scientific Abstracts (CSA)/ProQuest Chemical Abstracts Service/SciFinder CNKI Scholar EMBASE ERA 2018 Genamics Journal Seek Google Scholar Index Medicus International Pharmaceutical Abstracts J-Gate JournalTOCs MediaFinder®-Standard Periodical Directory MEDLINE/PubMed Norwegian Register OpenAire PubsHub QOAM Scilit Scopus Suweco CZ Ulrich's Periodicals Directory

Archiving and Copyright:

Portico Sherpa Romeo

Journal Database:

Dimensions

COPE Compliant

Archived in

Endorsement(s)

"Modern drug discovery is increasingly driven by scientific integration, the ability to pull together seemingly unrelated branches of basic and applied sciences to produce in a timely fashion innovative and efficacious solutions to multidisciplinary human health problems. The editorial staff is to be congratulated for providing a superb forum for publishing such science and the many and varied new directions that challenge how we think about and address drug discovery."

Paul A. Wender
Stanford University, USA